Aurobindo Pharma's Lyfius Pharma has temporarily halted Pen-G production at its Kakinada plant after a fire incident, with no injuries reported and minimal impact expected on opera...
Aurobindo Pharma's subsidiary, Auro Vaccines Pvt Ltd, has terminated its licensing agreement with Hilleman Laboratories for a pediatric pentavalent vaccine. The termination, effect...
Aurobindo Pharma reports that the USFDA inspected its subsidiary Apitoria Pharma's API manufacturing facility in Hyderabad with two procedural observations, to be addressed within ...
CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, received a positive opinion from EMA's CHMP for its filgrastim biosimilar, Zefylti. This marks the first biosimilar from Aurobi...
